---
title: Satisfaction With Placement of Implantable Venous Access Devices in Patients With Solid Tumors
nct_id: NCT01098643
overall_status: TERMINATED
phase: NA
sponsor: Vanderbilt University
study_type: INTERVENTIONAL
primary_condition: Unspecified Adult Solid Tumor, Protocol Specific
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT01098643.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT01098643"
ct_last_update_post_date: 2017-04-04
last_seen_at: "2026-05-12T06:46:53.985Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Satisfaction With Placement of Implantable Venous Access Devices in Patients With Solid Tumors

**Official Title:** Patient Satisfaction With Placement of Implantable Venous Access Devices

**NCT ID:** [NCT01098643](https://clinicaltrials.gov/study/NCT01098643)

## Key Facts

- **Status:** TERMINATED
- **Why Stopped:** not enough pts for available to reach goal
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 88
- **Lead Sponsor:** Vanderbilt University
- **Collaborators:** National Cancer Institute (NCI)
- **Conditions:** Unspecified Adult Solid Tumor, Protocol Specific
- **Start Date:** 2009-10
- **Completion Date:** 2011-09
- **CT.gov Last Update:** 2017-04-04

## Brief Summary

RATIONALE: Gathering information about patients with solid tumors who have implantable venous access devices may help doctors learn more about patient satisfaction.

PURPOSE: This phase I trial is studying satisfaction with placement of implantable venous access devices in patients with solid tumors.

## Detailed Description

OBJECTIVES:

* To determine patient satisfaction with subcutaneous venous-access device placement in oncology patients.

OUTLINE: Patients complete a computer-based survey while in the treatment area of the Vanderbilt Oncology Clinic. Basic demographic information and basic information regarding the placement of the device and complications are collected from the patient's medical record.

## Eligibility

- **Minimum age:** 18 Years
- **Maximum age:** 120 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
DISEASE CHARACTERISTICS:

* Diagnosis of a solid tumor malignancy

  * No hematological malignancy
* Patient at the Vanderbilt Oncology Clinic
* Has undergone placement of a subcutaneous, single-lumen venous-access device within the past 6 months

  * No patients who have had ≥ 2 venous-access devices placed by ≥ 1 department

PATIENT CHARACTERISTICS:

* Not specified

PRIOR CONCURRENT THERAPY:

* See Disease Characteristics
* Not currently undergoing preparation for or process of stem cell transplantation
```

## Interventions

- **computer-assisted intervention** (OTHER)
- **medical chart review** (OTHER)
- **questionnaire administration** (OTHER)
- **survey administration** (OTHER)

## Primary Outcomes

- **Overall satisfaction with port placement** _(time frame: n/a - study closed)_

## Secondary Outcomes

- **Frequency of complications**
- **Frequency of port failure**
- **Need for removal of device**

## Locations (2)

- Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville, Tennessee, United States
- Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.whyStopped` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.vanderbilt-ingram cancer center - cool springs|nashville|tennessee|united states` — added _(2026-05-12)_
- `locations.vanderbilt-ingram cancer center|nashville|tennessee|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT01098643.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT01098643*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*